top of page
News
Press Releases
Jul 30, 2020
Inflection Biosciences Announces Publication of Positive Data for IBL-202 in DLBCL.
Dublin, Ireland, July 30, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
May 12, 2020
Inflection Biosciences Announces Participation at Upcoming Industry Conferences.
Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Feb 19, 2020
Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.
Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Feb 6, 2020
Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
Jan 31, 2020
Inflection Biosciences to present at BIO CEO & Investor Conference 2020.
Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
bottom of page